Merdury Biopharmaceutical Corporation (TPEX:6932)
5.04
-0.14 (-2.70%)
Jul 30, 2026, 1:45 PM CST
-45.75% (1Y)
| Market Cap | 2.19B -45.0% |
| Revenue (ttm) | n/a |
| Net Income | -67.23M |
| EPS | -0.16 |
| Shares Out | 422.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 293,207 |
| Open | 5.18 |
| Previous Close | 5.18 |
| Day's Range | 4.91 - 5.19 |
| 52-Week Range | 4.91 - 12.20 |
| Beta | -1.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |